Skip to main content
. 2015 Aug 4;49(5):382–388. doi: 10.4132/jptm.2015.07.10

Fig. 2.

Fig. 2.

Kaplan-Meier survival analysis of progression-free survival and overall survival curves based on membranous insulin-like growth factor-1 receptor (IGF1R) expression. Membranous IGF1R expression had significantly better progression-free survival (A) and overall survival (B) in squamous cell carcinoma. Membranous IGF1R expression in epidermal growth factor receptor (EGFR)-mutant adenocarcinoma had significantly poor progression-free survival (C) and a trend toward poor overall survival (D).